Depression in women across the life cycle

Journal of Pharmacy Practice

Volumn 14, Issue 6, 2001, Pages 511-525

  Moore, Thea R ^a   Emanuel, Angela M ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Depression; Hormones; Life span; Pregnancy; Women

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BUSPIRONE; CLOMIPRAMINE; CYTOCHROME P450; DOXEPIN; FLUOXETINE; IMIPRAMINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THYROID HORMONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; AGED; BEHAVIOR THERAPY; BREAST FEEDING; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONGENITAL MALFORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG METABOLISM; DYSPHORIA; ELECTROCONVULSIVE THERAPY; FEMALE; HORMONE ACTION; HUMAN; MENTAL DISEASE; POSTMENOPAUSE; PREGNANCY; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PUERPERAL DEPRESSION; REVIEW; SEX DIFFERENCE; SPONTANEOUS ABORTION; SYMPTOMATOLOGY; TERATOGENICITY; VITAMIN DEFICIENCY;

EID: 0035204888     PISSN: 08971900     EISSN: None     Source Type: Journal    
DOI: 10.1177/089719001129040865     Document Type: Review

References (56)

1. Sex and depression in the National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence
2. Gender differences in depression: Implications for treatment
3. New strategies in the treatment of depression in women
4. Depression in women
5. Gender differences in the clinical features of unipolar major depressive disorder
6. Major depression in women: A review of the literature
7. Gender differences in presentation of chronic major depression
8. Atypical depression: Clinical aspects and noradrenergic function
9. Gender differences in pharmacokinetics and pharmacodynamics of psychotropics: Focus on women
10. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication
11. Estrogen, serotonin, and mood disturbance: Where is the thrapeutic bridge?
12. Mood disorders and the reproductive cycle: Affective disorders during the menopause and premenstrual dysphoric disorder
13. The role of fluoxetine in the treatment of premenstrual dysphoric disorder
14. Predictors of response to sertraline treatment of severe premenstrual syndromes
15. The association between premenstrual dysphoric disorder and other mood disorders
16. New indications for antidepressants
17. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment: A randomized control trial
18. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: A randomized, double-blind, placebo-controlled crossover trial
19. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo
20. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder
21. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder; a randomized controlled trial
22. Depression during pregnancy and the puerperium
23. Treatment issues during pregnancy and lactation
24. Course of mood and anxiety disorders during pregnancy and the postpartum period
25. Enhancing pharmacologic effects in the treatment of depression in women
26. Pharmacologic mangement of psychiatric illness during pregnancy: Dilemmas and guidelines
27. Delivery outcome after the use of antidepressants in early pregnancy
28. Birth outcomes in pregnat women taking fluoxetine
29. Pregnancy outcome following first-trimester exposure to fluoxetine
30. Pregnancy oucome following maternal use of the new serotonin reuptake inhibitors: A prospective controlled multicenter study
31. Neurodevelopment of children exposed in utero to antidepressant drugs
32. The use of selective serotonin reuptake inhibitors during pregnancy and lactation: Current knowledge
33. Effects of first trimester fluoxetine exposure on the newborn
34. Psychotropic drug use during pregnancy: Weighing the risks
35. Pharmacologic treatment of depression during pregnancy
36. Postpartum mood disorders: Diagnosis and treatment guidelines
37. Psychotropic medications in lactation
38. A controlled study of fluoxetine and cognitive-behavioral counselling in the treatment of postnatal depression
39. Antidepressant treatment during breast-feeding
40. Effects of antidepressants during pregnancy and lactation
41. Epidemiology and diagnosis of depression in late life
42. Therapeutic options in treating depression
43. Changing views: The emergence and efficacy of natural hormones in the treatment of menopause
44. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-gonadal axis
45. Role of estrogen in postmenopausal depression
46. Mood disorders and menopause
47. Psychiatric morbidity in endocrine disorders
48. The symptoms of depression in endocrine disorders
49. Identification and treatment of geriatric depression
50. Pharmacokinetic considerations of antidepressant use in the elderly
51. Problems with currently available antidepressants
52. Adverse reactions of antidepressant in elderly patients